EASY TO USE, LOW-COST MOLECULAR-BASED SARS-COV-2 TEST, HIGHLY SCALABLE RAPID ACCELERATION OF DIAGNOSTICS (RADX) PROGRAM: TECH PROJECT #2244 MESA BIOTECH, INC.
$34,726,764
| Recipient | MESA BIOTECH INC UEI NCEGPN78SNF7 |
|---|---|
| Award ID | 75N92020C00014 |
| Award amount | $34,726,764 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — National Institutes of Health |
| NAICS | 334516 — ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING |
| PSC | Q301 |
| Start date | Jul 30, 2020 |
| End date | May 4, 2024 |
| Place of performance | SAN DIEGO, CA |
| Record updated | Jan 28, 2023 |
View the official award record
More awards won by MESA BIOTECH INC
ACCULA FLU/SARS-COV-2 INTEGRATED TEST DEVELOPMENT
Department of Health and Human Services · $12,503,777 · Nov 5, 2020
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids